EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Articles|August 24, 2010
Would You Offer Reassurance--or Biopsy?
A 24-year-old man is concerned about a large, hairy "mole" on his left shoulder. The lesion appeared during adolescence as a group of small, dark blotches. These eventually coalesced into a hyperpigmented patch with hair and acne.
Advertisement
A 24-year-old man is concerned about a large, hairy "mole" on his left shoulder. The lesion appeared during adolescence as a group of small, dark blotches. These eventually coalesced into a hyperpigmented patch with hair and acne.
Would you biopsy this lesion?
(Case and photo courtesy of Kendall Lane, MD.)
Answer: Becker Nevus
For more information about this case,
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Advertisement
Advertisement
Trending on Patient Care Online
1
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
2
CagriSema Cuts Weight Up to 27% Across Menopause Stages: TMS 2026
3
New Study Finds Low Initiation, Persistence With Menopause Hormone Therapy
4
When Night Sweats Signal Something Other Than Menopause
5